Navigation Links
Novel Approach to Improving Cardiovascular Care
Date:10/5/2007

To Advance Heart Care Treatment, Physician Program at Montefiore Will Measure Everything from Aspirin and Beta Blockers to Patient Satisfaction

NEW YORK, Oct. 5 /PRNewswire-USNewswire/ -- Thousands of heart patients in the Greater New York region will receive top quality, comprehensive cardiac care in an innovative cardiovascular program in which physicians at a major academic medical center will receive incentive payments based on 60 performance measures for outpatient and inpatient care.

The program is one of many pioneering initiatives at Montefiore Medical Center's nationally recognized Montefiore-Einstein Heart Center and will challenge physicians to score well on a mix of measurable activities that indicate quality care for patients, such as: is the patient enrolled in a smoking cessation program; has beta blocker therapy been persistent; is blood pressure under control; and, was the patient generally satisfied with his care? The program is for heart patients and for patients with risk factors for heart disease, such as diabetes, hypertension, hypercholesterolemia, smoking and obesity.

Montefiore is the only hospital in New York State to initiate such a pay- for-performance program, which is being funded by a $2.4 million grant from the New York State Health Department.

"Cardiovascular care has advanced considerably over the past decades through prevention programs, clinical drug trials and advancements in surgery such as robotics," said Steven M. Safyer, MD, Senior Vice President and Chief Medical Officer, Montefiore. "This state grant supports Montefiore's continuing focus on innovations in cardiovascular treatment by adding a new approach. It gives us the opportunity to look at the physician side of the equation and to implement a model pay-for-performance cardiac care program."

Here's how the pay-for-performance project will work in an outpatient setting for one group of patients -- those who are at-risk for heart dise
'/>"/>

SOURCE Montefiore Medical Center
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Gene enchances radiation therapy - A novel approach to fight cancer
3. A novel augmentation
4. Novel biopsy technique for prostate cancer
5. Novel computer model for breast cancer
6. Novel research on liver cancer
7. Novel way to fight cancer
8. Novel test for bowel cancer
9. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
10. Novel Therapy for Chronic Problem
11. Blood Sugar Kept In Control By Novel Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... of Alzheimer,s disease has been a rapidly evolving ... the latest crook in the research road, scientists ... between proteins associated with the disease. The report, ... Neuroscience , could have important implications for developing ... and colleagues explain that for years, research has ...
(Date:4/22/2014)... Jersey Institute of Technology (NJIT) today to join ... of the New Jersey Innovation Institute (NJII), an ... business innovation through the leveraging of industry, government, ... Cory Booker, Panasonic Corp. of North America Chairman ... Kim Guadagno, New Jersey Secretary of Higher Education ...
(Date:4/22/2014)... have characterized a set of clock genes that drive ... of species, from flies to humans. Over 15 mammalian ... are more. A team from the Perelman School of ... approaches could find them. , To accelerate clock-gene ... of Pharmacology and first author Ron Anafi, MD, PhD, ...
(Date:4/22/2014)... Researchers at UT Southwestern Medical Center are making breakthroughs ... , A team of physician-scientists at UT Southwestern ... hormone with natural anti-depressant properties) works inside the brain. ... for depression in the form of a neuroprotective drug ... online in April,s issue of Molecular Psychiatry, ...
(Date:4/22/2014)... (SACRAMENTO, Calif.) The risk of pregnancy among women ... sterilization is more than 10 times greater over a ... sterilization, a study by researchers at Yale University and ... in the medical journal Contraception , the study ... sterilization method marketed under the brand name Essure. ...
Breaking Medicine News(10 mins):Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Bioinformatics profiling identifies a new mammalian clock gene 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:Risk of pregnancy greater with newer method of female sterilization 2Health News:Risk of pregnancy greater with newer method of female sterilization 3
... Health Services, Inc. (NYSE: UHS ) announced ... a cash dividend of $0.08 per share on June ... 1, 2009.Universal Health Services, Inc. is one of the ... care and behavioral health hospitals, and ambulatory centers nationwide ...
... Examined For Skin CancerYONKERS, N.Y., May 20 Thirty-one percent of ... National Research Center said they never wear sunscreen. ... of those polled said they,d been examined by a doctor for ... of Consumer Reports rates ten top selling sunscreens to ...
... the strain is related to flu variant that circulated before ... people may have partial immunity to the new H1N1 swine ... strain circulating prior to 1957, a U.S. infectious-disease expert said ... more likely you are to have been exposed to H1N1 ...
... when even teens who have never tried a drop of alcohol ... big events and there will be multiple parties to attend and ... , Assume that your child will be tempted to drink alcohol ... Inside Alcohol Project of the American Association for the Advancement of ...
... Small Business Membership process, which eliminates more than a dozen formal ... qualify with a business card or letterhead. , ... ... series of pro-small business initiatives aimed to help small business owners ...
... Orasi Medical, Inc. announced today that it has completed ... use this capital to expand the development and use ... markets. Pharmaceutical companies will use this test to determine ... diseases. Orasi is currently in discussions with several pharmaceutical ...
Cached Medicine News:Health News:Consumer Reports Poll: Thirty-One Percent of Americans Never Use Sunscreen 2Health News:Consumer Reports Poll: Thirty-One Percent of Americans Never Use Sunscreen 3Health News:Consumer Reports Poll: Thirty-One Percent of Americans Never Use Sunscreen 4Health News:Older Adults May Have Some Immunity to Swine Flu 2Health News:Older Adults May Have Some Immunity to Swine Flu 3Health News:Older Adults May Have Some Immunity to Swine Flu 4Health News:Older Adults May Have Some Immunity to Swine Flu 5Health News:Older Adults May Have Some Immunity to Swine Flu 6Health News:Older Adults May Have Some Immunity to Swine Flu 7Health News:Older Adults May Have Some Immunity to Swine Flu 8Health News:Older Adults May Have Some Immunity to Swine Flu 9Health News:Older Adults May Have Some Immunity to Swine Flu 10Health News:Older Adults May Have Some Immunity to Swine Flu 11Health News:Older Adults May Have Some Immunity to Swine Flu 12Health News:Older Adults May Have Some Immunity to Swine Flu 13Health News:Use science to convince teens a sober prom is better, AAAS says 2Health News:National Small Business Week Update: Sam's Club Announces Simplified Small Business Membership; Partnership With U.S. Chamber of Commerce, Plus Free One-Day Pass 2Health News:National Small Business Week Update: Sam's Club Announces Simplified Small Business Membership; Partnership With U.S. Chamber of Commerce, Plus Free One-Day Pass 3
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced ... older adults suffering from the severe cold weather that has ... committed to helping those in need; so to support these ... contributions up to $250,000, which could mean up to $500,000 ...
(Date:1/15/2014)... 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will receive ... Journal of Drugs in Dermatology (JDD) at the ... event is January 17-20, 2014, at the Omni Orlando Resort at ... The ODAC is a distinguished event that delivers ...
(Date:1/15/2014)... 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... application concerning composition of matter, biological targets, mechanism of ... death.  This patent application describes a ... molecules (VSRNAs) which interfere with the basic homeostatic cellular ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
...  BioDelivery Sciences International, Inc. (Nasdaq: BDSI ... license and development agreement with Endo Pharmaceuticals (Nasdaq: ... to develop and commercialize BEMA Buprenorphine for the ... patented and proven BioErodible MucoAdhesive (BEMA) technology to ...
... conjunction with its fourth quarter 2011 earnings release (expected to ... Inc. (NYSE: CVD ) is pleased to invite ... will be broadcast live over the Internet on Thursday, January ... , What:       , , , Covance Fourth Quarter 2011 Earnings ...
Cached Medicine Technology:BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine 2BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine 3BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine 4BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine 5
First to USA-market, this revolutionary technology combines CBC and CRP analysis for stat results of 17 parameters within 4.5 minutes!...
StarClose Clip Applier, (includes), Clip Applier, 6F Exchange Sheath, 6F Dilator, 0.038 50 cm J-Tip Guide Wire ...
... 5.5x magnification., ,Higher magnification for advanced ... true image. Edge to edge clarity ... for intricate surgical applications. The XL's ... anti-reflective coating to produce a superior ...
... and 3.0x magnification. The true benefit of ... while maintaining focal clarity is made possible ... The lightweight aluminum bar and individual pupillary ... and optimal focal alignment, eliminating headache and ...
Medicine Products: